 |
TABLE OF CONTENTS
|  |  |  | Volume 6, June 2016 |  | In this issue Commentary Original Articles Letters to the Editor | |  |  |  | | Advertisement |  | Blood Cancer Journal is an online-only, open access journal, publishing high quality research on hematologic malignancies and related disorders. The journal has an Impact Factor of 3.467.
Explore the benefits of submitting your next research article. |  | | |  |  | Commentary | Top |  | Obinutuzumab-induced coagulopathy in chronic lymphocytic leukaemia with trisomy 12H S Walter, S Jayne, P Mensah, F M Miall, M Lyttelton and M J S Dyer Blood Cancer J 2016 6: e435; 10.1038/bcj.2016.42 Full Text |  | Original Articles | Top |  | A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cellsE Calura, S Pizzini, A Bisognin, A Coppe, G Sales, E Gaffo, T Fanelli, C Mannarelli, R Zini, R Norfo, V Pennucci, R Manfredini, C Romualdi, P Guglielmelli, A M Vannucchi and S Bortoluzzi on behalf of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative (AGIMM) Investigators Blood Cancer J 2016 6: e439; 10.1038/bcj.2016.47 Abstract | Full Text |  |  |  | Systemic TLR2 agonist exposure regulates hematopoietic stem cells via cell-autonomous and cell-non-autonomous mechanismsA C Herman, D A Monlish, M P Romine, S T Bhatt, S Zippel and L G Schuettpelz Blood Cancer J 2016 6: e437; 10.1038/bcj.2016.45 Abstract | Full Text |  |  |  | p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLLH J Lee, M Gallardo, H Ma, X Zhang, C A Larsson, A Mejia, M J Hornbaker, Y Qi, X Su, L R Pageon, A Quintas-Cardama and S M Post Blood Cancer J 2016 6: e434; 10.1038/bcj.2016.41 Abstract | Full Text |  |  |  | Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in miceX Liu, D M Barrett, S Jiang, C Fang, M Kalos, S A Grupp, C H June and Y Zhao Blood Cancer J 2016 6: e430; 10.1038/bcj.2016.38 Abstract | Full Text |  |  |  | Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targetsA Maiga, S Lemieux, C Pabst, V-P Lavallée, M Bouvier, G Sauvageau and J Hébert Blood Cancer J 2016 6: e431; 10.1038/bcj.2016.36 Abstract | Full Text |  | Letters to the Editor | Top |  | Leukocytosis and presence of CALR mutation is associated with non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosisD Barraco, T L Lasho, N Gangat, C Finke, Y C Elala, A Pardanani and A Tefferi Blood Cancer J 2016 6: e436; 10.1038/bcj.2016.44 Full Text |  |  |  | 3R gene expression in chronic lymphocytic leukemia reveals insight into disease evolutionS Grgurevic, L Berquet, A Quillet-Mary, G Laurent, C Récher, L Ysebaert, C Cazaux and J S Hoffmann Blood Cancer J 2016 6: e429; 10.1038/bcj.2016.39 Full Text |  |  |  | Lichenoid drug eruption associated with BendamustineY Kusano, Y Terui, M Yokoyama and K Hatake Blood Cancer J 2016 6: e438; 10.1038/bcj.2016.48 Full Text |  |  |  | Predicting the response of multiple myeloma to the proteasome inhibitor Bortezomib by evaluation of the unfolded protein responseN Nikesitch, C Tao, K Lai, M Killingsworth, S Bae, M Wang, S Harrison, T L Roberts and S C W Ling Blood Cancer J 2016 6: e432; 10.1038/bcj.2016.40 Full Text |  |  |  | Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphomaC Pommerenke, V Hauer, M Zaborski, R A F MacLeod, S Nagel, R M Amini, M Berglund, R Geffers, H G Drexler and H Quentmeier Blood Cancer J 2016 6: e433; 10.1038/bcj.2016.43 Full Text |  |  |  |  | You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment